4//SEC Filing
Stegagno Peter 4
Accession 0001437749-25-011179
CIK 0001417663other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:07 PM ET
Size
48.3 KB
Accession
0001437749-25-011179
Insider Transaction Report
Form 4
Stegagno Peter
Chief Operating Officer
Transactions
- Disposition to Issuer
Class N Warrant (right to buy)
2019-01-23−885→ 0 totalExercise: $0.00From: 2017-12-21Exp: 2019-03-17→ Common Stock (885 underlying) - Award
Stock Option (right to buy)
2016-06-16+1,333→ 1,333 totalExercise: $15.00Exp: 2026-06-16→ Common Stock (1,333 underlying) - Award
Stock Option (right to buy)
2016-11-09+1,132→ 1,132 totalExercise: $67.50Exp: 2026-11-09→ Common Stock (1,132 underlying) - Award
Stock Option (right to buy)
2017-06-15+1,600→ 1,600 totalExercise: $41.25Exp: 2027-06-15→ Common Stock (1,600 underlying) - Award
Stock Option (right to buy)
2018-09-20+2,000→ 2,000 totalExercise: $78.75Exp: 2028-09-20→ Common Stock (2,000 underlying) - Award
Class N Warrant (right to buy)
2019-05-31+885→ 885 totalExercise: $0.00From: 2019-05-31Exp: 2019-09-03→ Common Stock (885 underlying) - Exercise/Conversion
Class O Warrant (right to buy)
2019-08-29−1,141→ 0 totalExercise: $0.00From: 2019-05-31Exp: 2019-09-03→ Common Stock (1,141 underlying) - Award
Stock Option (right to buy)
2024-10-22+40,000→ 40,000 totalExercise: $14.20Exp: 2034-10-22→ Common Stock (40,000 underlying) - Award
Common Stock
2019-08-29+885→ 891 total - Disposition to Issuer
Class N Warrant (right to buy)
2019-05-01−885→ 0 totalExercise: $0.00From: 2019-01-23Exp: 2019-05-01→ Common Stock (885 underlying) - Disposition to Issuer
Class N Warrant (right to buy)
2019-05-31−885→ 0 totalExercise: $0.00From: 2019-05-01Exp: 2019-06-28→ Common Stock (885 underlying) - Exercise/Conversion
Class N Warrant (right to buy)
2019-08-29−885→ 0 totalExercise: $0.00From: 2019-05-31Exp: 2019-09-03→ Common Stock (885 underlying) - Award
Common Stock
2019-08-29+1,141→ 2,032 total - Award
Class N Warrant (right to buy)
2017-12-21$0.00/sh+885$0→ 885 totalExercise: $0.00From: 2017-12-21Exp: 2019-03-17→ Common Stock (885 underlying) - Award
Class N Warrant (right to buy)
2019-01-23+885→ 885 totalExercise: $0.00From: 2019-01-23Exp: 2019-05-01→ Common Stock (885 underlying) - Award
Class N Warrant (right to buy)
2019-05-01+885→ 885 totalExercise: $0.00From: 2019-05-01Exp: 2019-06-28→ Common Stock (885 underlying) - Award
Stock Option (right to buy)
2019-08-26+133→ 133 totalExercise: $56.25Exp: 2029-08-26→ Common Stock (133 underlying) - Award
Class O Warrant (right to buy)
2017-12-11+1,141→ 1,141 totalExercise: $0.00From: 2017-12-11Exp: 2019-03-17→ Common Stock (1,141 underlying) - Disposition to Issuer
Class O Warrant (right to buy)
2019-03-01−1,141→ 0 totalExercise: $0.00From: 2017-12-11Exp: 2019-03-17→ Common Stock (1,141 underlying) - Disposition to Issuer
Class O Warrant (right to buy)
2019-05-31−1,141→ 0 totalExercise: $0.00From: 2019-03-01Exp: 2019-06-28→ Common Stock (1,141 underlying) - Award
Class O Warrant (right to buy)
2019-03-01+1,141→ 1,141 totalExercise: $0.00From: 2019-03-01Exp: 2019-06-28→ Common Stock (1,141 underlying) - Award
Class O Warrant (right to buy)
2019-05-31+1,141→ 1,141 totalExercise: $0.00From: 2019-05-31Exp: 2019-09-03→ Common Stock (1,141 underlying)
Footnotes (10)
- [F1]On August 29, 2019, the reporting person exercised the Class N Warrants for 885 shares of common stock of Sanuwave Health, Inc. (the "Company") at an exercise price of $0.00029 per share.
- [F10]Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date.
- [F2]On August 29, 2019, the reporting person exercised the Class O Warrants for 1,141 shares of the Company's common stock at an exercise price of $0.00029 per share.
- [F3]On January 23, 2019, the Company extended the expiration date of the Class N Warrants to May 1, 2019.
- [F4]On May 1, 2019, the Company extended the expiration date of the Class N Warrants to June 28, 2019.
- [F5]On May 31, 2019, the Company extended the expiration date of the Class N Warrants to September 3, 2019.
- [F6]On December 11, 2017, the reporting person received Class O Warrants exercisable for 1,141 shares of common stock at an exercise price of $0.00029 per share as compensation.
- [F7]On March 1, 2019, the Company extended the expiration date of the Class O Warrants to June 28, 2019.
- [F8]On May 31, 2019, the Company extended the expiration date of the Class O Warrants to September 3, 2019.
- [F9]Options were fully vested at the grant date.
Documents
Issuer
SANUWAVE Health, Inc.
CIK 0001417663
Entity typeother
Related Parties
1- filerCIK 0002012443
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 4:07 PM ET
- Size
- 48.3 KB